ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cyclosporine API Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-34P13564
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cyclosporine API Market Research Report 2023
BUY CHAPTERS

Global Cyclosporine API Market Research Report 2025

Code: QYRE-Auto-34P13564
Report
March 2025
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Curia Italy Srl
Teva Pharmaceutical Industries Ltd
North China Pharmaceutical Huasheng Co Ltd.
Concord Biotech Ltd.
APOTEX PHARMACHEM INC
ChemWerth Inc
AbbVie
Hangzhou Zhongmei Huadong Pharmaceutical Co. LTD
Fujian Kerui Pharmaceutical
North China Pharmaceutical Huasheng
CKD BIO CORP
Guangdong Tesunde Pharmaceutical
Sinopharm Sichuan Kang Pharmaceutical
Jiangsu Joyoung Biopharmaceuticals
Zhejiang Ruibang Laboratories

Cyclosporine API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cyclosporine API Market

Cyclosporine API Market

The global market for Cyclosporine API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cyclosporine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclosporine API.
The Cyclosporine API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cyclosporine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cyclosporine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cyclosporine API Market Report

Report Metric Details
Report Name Cyclosporine API Market
CAGR 5%
by Type
  • Purity≥99%
  • Purity<99%
by Application
  • Capsule
  • Tablet
  • Injection
  • Eye Drops
  • Eye Gel
  • Eye Cream
  • Oral Solution
  • Granules
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CURIA ITALY SRL, TEVA PHARMACEUTICAL INDUSTRIES LTD, NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD, CONCORD BIOTECH LTD, APOTEX PHARMACHEM INC, CHEMWERTH INC, ABBVIE INC, CKD BIO CORP, ZHEJIANG RUIBANG LABORATORIES, HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD, Guangdong Tesunde Pharmaceutical, Fujian Kerui Pharmaceutical, North China Pharmaceutical Huasheng, Sinopharm Sichuan Kang Pharmaceutical, Jiangsu Joyoung Biopharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cyclosporine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Cyclosporine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Cyclosporine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cyclosporine API Market report?

Ans: The main players in the Cyclosporine API Market are CURIA ITALY SRL, TEVA PHARMACEUTICAL INDUSTRIES LTD, NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD, CONCORD BIOTECH LTD, APOTEX PHARMACHEM INC, CHEMWERTH INC, ABBVIE INC, CKD BIO CORP, ZHEJIANG RUIBANG LABORATORIES, HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD, Guangdong Tesunde Pharmaceutical, Fujian Kerui Pharmaceutical, North China Pharmaceutical Huasheng, Sinopharm Sichuan Kang Pharmaceutical, Jiangsu Joyoung Biopharmaceuticals

What are the Application segmentation covered in the Cyclosporine API Market report?

Ans: The Applications covered in the Cyclosporine API Market report are Capsule, Tablet, Injection, Eye Drops, Eye Gel, Eye Cream, Oral Solution, Granules

What are the Type segmentation covered in the Cyclosporine API Market report?

Ans: The Types covered in the Cyclosporine API Market report are Purity≥99%, Purity<99%

Recommended Reports

API Markets

Therapeutic APIs

Specialty Drug Markets

1 Cyclosporine API Market Overview
1.1 Product Definition
1.2 Cyclosporine API by Type
1.2.1 Global Cyclosporine API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Cyclosporine API by Application
1.3.1 Global Cyclosporine API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Capsule
1.3.3 Tablet
1.3.4 Injection
1.3.5 Eye Drops
1.3.6 Eye Gel
1.3.7 Eye Cream
1.3.8 Oral Solution
1.3.9 Granules
1.4 Global Market Growth Prospects
1.4.1 Global Cyclosporine API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Cyclosporine API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Cyclosporine API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Cyclosporine API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Cyclosporine API Production Market Share by Manufacturers (2020-2025)
2.2 Global Cyclosporine API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Cyclosporine API, Industry Ranking, 2023 VS 2024
2.4 Global Cyclosporine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Cyclosporine API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Cyclosporine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Cyclosporine API, Product Offered and Application
2.8 Global Key Manufacturers of Cyclosporine API, Date of Enter into This Industry
2.9 Cyclosporine API Market Competitive Situation and Trends
2.9.1 Cyclosporine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Cyclosporine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Cyclosporine API Production by Region
3.1 Global Cyclosporine API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Cyclosporine API Production Value by Region (2020-2031)
3.2.1 Global Cyclosporine API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Cyclosporine API by Region (2026-2031)
3.3 Global Cyclosporine API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Cyclosporine API Production Volume by Region (2020-2031)
3.4.1 Global Cyclosporine API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Cyclosporine API by Region (2026-2031)
3.5 Global Cyclosporine API Market Price Analysis by Region (2020-2025)
3.6 Global Cyclosporine API Production and Value, Year-over-Year Growth
3.6.1 North America Cyclosporine API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Cyclosporine API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Cyclosporine API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Cyclosporine API Production Value Estimates and Forecasts (2020-2031)
4 Cyclosporine API Consumption by Region
4.1 Global Cyclosporine API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Cyclosporine API Consumption by Region (2020-2031)
4.2.1 Global Cyclosporine API Consumption by Region (2020-2025)
4.2.2 Global Cyclosporine API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Cyclosporine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Cyclosporine API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Cyclosporine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Cyclosporine API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Cyclosporine API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Cyclosporine API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Cyclosporine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Cyclosporine API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Cyclosporine API Production by Type (2020-2031)
5.1.1 Global Cyclosporine API Production by Type (2020-2025)
5.1.2 Global Cyclosporine API Production by Type (2026-2031)
5.1.3 Global Cyclosporine API Production Market Share by Type (2020-2031)
5.2 Global Cyclosporine API Production Value by Type (2020-2031)
5.2.1 Global Cyclosporine API Production Value by Type (2020-2025)
5.2.2 Global Cyclosporine API Production Value by Type (2026-2031)
5.2.3 Global Cyclosporine API Production Value Market Share by Type (2020-2031)
5.3 Global Cyclosporine API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Cyclosporine API Production by Application (2020-2031)
6.1.1 Global Cyclosporine API Production by Application (2020-2025)
6.1.2 Global Cyclosporine API Production by Application (2026-2031)
6.1.3 Global Cyclosporine API Production Market Share by Application (2020-2031)
6.2 Global Cyclosporine API Production Value by Application (2020-2031)
6.2.1 Global Cyclosporine API Production Value by Application (2020-2025)
6.2.2 Global Cyclosporine API Production Value by Application (2026-2031)
6.2.3 Global Cyclosporine API Production Value Market Share by Application (2020-2031)
6.3 Global Cyclosporine API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 CURIA ITALY SRL
7.1.1 CURIA ITALY SRL Cyclosporine API Company Information
7.1.2 CURIA ITALY SRL Cyclosporine API Product Portfolio
7.1.3 CURIA ITALY SRL Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 CURIA ITALY SRL Main Business and Markets Served
7.1.5 CURIA ITALY SRL Recent Developments/Updates
7.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
7.2.1 TEVA PHARMACEUTICAL INDUSTRIES LTD Cyclosporine API Company Information
7.2.2 TEVA PHARMACEUTICAL INDUSTRIES LTD Cyclosporine API Product Portfolio
7.2.3 TEVA PHARMACEUTICAL INDUSTRIES LTD Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 TEVA PHARMACEUTICAL INDUSTRIES LTD Main Business and Markets Served
7.2.5 TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
7.3 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD
7.3.1 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Cyclosporine API Company Information
7.3.2 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Cyclosporine API Product Portfolio
7.3.3 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Main Business and Markets Served
7.3.5 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Recent Developments/Updates
7.4 CONCORD BIOTECH LTD
7.4.1 CONCORD BIOTECH LTD Cyclosporine API Company Information
7.4.2 CONCORD BIOTECH LTD Cyclosporine API Product Portfolio
7.4.3 CONCORD BIOTECH LTD Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 CONCORD BIOTECH LTD Main Business and Markets Served
7.4.5 CONCORD BIOTECH LTD Recent Developments/Updates
7.5 APOTEX PHARMACHEM INC
7.5.1 APOTEX PHARMACHEM INC Cyclosporine API Company Information
7.5.2 APOTEX PHARMACHEM INC Cyclosporine API Product Portfolio
7.5.3 APOTEX PHARMACHEM INC Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 APOTEX PHARMACHEM INC Main Business and Markets Served
7.5.5 APOTEX PHARMACHEM INC Recent Developments/Updates
7.6 CHEMWERTH INC
7.6.1 CHEMWERTH INC Cyclosporine API Company Information
7.6.2 CHEMWERTH INC Cyclosporine API Product Portfolio
7.6.3 CHEMWERTH INC Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 CHEMWERTH INC Main Business and Markets Served
7.6.5 CHEMWERTH INC Recent Developments/Updates
7.7 ABBVIE INC
7.7.1 ABBVIE INC Cyclosporine API Company Information
7.7.2 ABBVIE INC Cyclosporine API Product Portfolio
7.7.3 ABBVIE INC Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 ABBVIE INC Main Business and Markets Served
7.7.5 ABBVIE INC Recent Developments/Updates
7.8 CKD BIO CORP
7.8.1 CKD BIO CORP Cyclosporine API Company Information
7.8.2 CKD BIO CORP Cyclosporine API Product Portfolio
7.8.3 CKD BIO CORP Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 CKD BIO CORP Main Business and Markets Served
7.8.5 CKD BIO CORP Recent Developments/Updates
7.9 ZHEJIANG RUIBANG LABORATORIES
7.9.1 ZHEJIANG RUIBANG LABORATORIES Cyclosporine API Company Information
7.9.2 ZHEJIANG RUIBANG LABORATORIES Cyclosporine API Product Portfolio
7.9.3 ZHEJIANG RUIBANG LABORATORIES Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 ZHEJIANG RUIBANG LABORATORIES Main Business and Markets Served
7.9.5 ZHEJIANG RUIBANG LABORATORIES Recent Developments/Updates
7.10 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD
7.10.1 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Cyclosporine API Company Information
7.10.2 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Cyclosporine API Product Portfolio
7.10.3 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Main Business and Markets Served
7.10.5 HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Recent Developments/Updates
7.11 Guangdong Tesunde Pharmaceutical
7.11.1 Guangdong Tesunde Pharmaceutical Cyclosporine API Company Information
7.11.2 Guangdong Tesunde Pharmaceutical Cyclosporine API Product Portfolio
7.11.3 Guangdong Tesunde Pharmaceutical Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Guangdong Tesunde Pharmaceutical Main Business and Markets Served
7.11.5 Guangdong Tesunde Pharmaceutical Recent Developments/Updates
7.12 Fujian Kerui Pharmaceutical
7.12.1 Fujian Kerui Pharmaceutical Cyclosporine API Company Information
7.12.2 Fujian Kerui Pharmaceutical Cyclosporine API Product Portfolio
7.12.3 Fujian Kerui Pharmaceutical Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Fujian Kerui Pharmaceutical Main Business and Markets Served
7.12.5 Fujian Kerui Pharmaceutical Recent Developments/Updates
7.13 North China Pharmaceutical Huasheng
7.13.1 North China Pharmaceutical Huasheng Cyclosporine API Company Information
7.13.2 North China Pharmaceutical Huasheng Cyclosporine API Product Portfolio
7.13.3 North China Pharmaceutical Huasheng Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 North China Pharmaceutical Huasheng Main Business and Markets Served
7.13.5 North China Pharmaceutical Huasheng Recent Developments/Updates
7.14 Sinopharm Sichuan Kang Pharmaceutical
7.14.1 Sinopharm Sichuan Kang Pharmaceutical Cyclosporine API Company Information
7.14.2 Sinopharm Sichuan Kang Pharmaceutical Cyclosporine API Product Portfolio
7.14.3 Sinopharm Sichuan Kang Pharmaceutical Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Sinopharm Sichuan Kang Pharmaceutical Main Business and Markets Served
7.14.5 Sinopharm Sichuan Kang Pharmaceutical Recent Developments/Updates
7.15 Jiangsu Joyoung Biopharmaceuticals
7.15.1 Jiangsu Joyoung Biopharmaceuticals Cyclosporine API Company Information
7.15.2 Jiangsu Joyoung Biopharmaceuticals Cyclosporine API Product Portfolio
7.15.3 Jiangsu Joyoung Biopharmaceuticals Cyclosporine API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Jiangsu Joyoung Biopharmaceuticals Main Business and Markets Served
7.15.5 Jiangsu Joyoung Biopharmaceuticals Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Cyclosporine API Industry Chain Analysis
8.2 Cyclosporine API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Cyclosporine API Production Mode & Process Analysis
8.4 Cyclosporine API Sales and Marketing
8.4.1 Cyclosporine API Sales Channels
8.4.2 Cyclosporine API Distributors
8.5 Cyclosporine API Customer Analysis
9 Cyclosporine API Market Dynamics
9.1 Cyclosporine API Industry Trends
9.2 Cyclosporine API Market Drivers
9.3 Cyclosporine API Market Challenges
9.4 Cyclosporine API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
Curia Italy Srl
Teva Pharmaceutical Industries Ltd
North China Pharmaceutical Huasheng Co Ltd.
Concord Biotech Ltd.
APOTEX PHARMACHEM INC
ChemWerth Inc
AbbVie
Hangzhou Zhongmei Huadong Pharmaceutical Co. LTD
Fujian Kerui Pharmaceutical
North China Pharmaceutical Huasheng
CKD BIO CORP
Guangdong Tesunde Pharmaceutical
Sinopharm Sichuan Kang Pharmaceutical
Jiangsu Joyoung Biopharmaceuticals
Zhejiang Ruibang Laboratories
List of Tables
 Table 1. Global Cyclosporine API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Cyclosporine API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Cyclosporine API Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Cyclosporine API Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Cyclosporine API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Cyclosporine API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Cyclosporine API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Cyclosporine API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Cyclosporine API as of 2024)
 Table 10. Global Market Cyclosporine API Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of Cyclosporine API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Cyclosporine API, Product Offered and Application
 Table 13. Global Key Manufacturers of Cyclosporine API, Date of Enter into This Industry
 Table 14. Global Cyclosporine API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cyclosporine API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Cyclosporine API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Cyclosporine API Production Value Market Share by Region (2020-2025)
 Table 19. Global Cyclosporine API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Cyclosporine API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Cyclosporine API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Cyclosporine API Production (Tons) by Region (2020-2025)
 Table 23. Global Cyclosporine API Production Market Share by Region (2020-2025)
 Table 24. Global Cyclosporine API Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Cyclosporine API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Cyclosporine API Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global Cyclosporine API Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global Cyclosporine API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Cyclosporine API Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Cyclosporine API Consumption Market Share by Region (2020-2025)
 Table 31. Global Cyclosporine API Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Cyclosporine API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Cyclosporine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Cyclosporine API Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Cyclosporine API Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Cyclosporine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Cyclosporine API Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Cyclosporine API Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Cyclosporine API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Cyclosporine API Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Cyclosporine API Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Cyclosporine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Cyclosporine API Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Cyclosporine API Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Cyclosporine API Production (Tons) by Type (2020-2025)
 Table 46. Global Cyclosporine API Production (Tons) by Type (2026-2031)
 Table 47. Global Cyclosporine API Production Market Share by Type (2020-2025)
 Table 48. Global Cyclosporine API Production Market Share by Type (2026-2031)
 Table 49. Global Cyclosporine API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Cyclosporine API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Cyclosporine API Production Value Market Share by Type (2020-2025)
 Table 52. Global Cyclosporine API Production Value Market Share by Type (2026-2031)
 Table 53. Global Cyclosporine API Price (US$/Ton) by Type (2020-2025)
 Table 54. Global Cyclosporine API Price (US$/Ton) by Type (2026-2031)
 Table 55. Global Cyclosporine API Production (Tons) by Application (2020-2025)
 Table 56. Global Cyclosporine API Production (Tons) by Application (2026-2031)
 Table 57. Global Cyclosporine API Production Market Share by Application (2020-2025)
 Table 58. Global Cyclosporine API Production Market Share by Application (2026-2031)
 Table 59. Global Cyclosporine API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Cyclosporine API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Cyclosporine API Production Value Market Share by Application (2020-2025)
 Table 62. Global Cyclosporine API Production Value Market Share by Application (2026-2031)
 Table 63. Global Cyclosporine API Price (US$/Ton) by Application (2020-2025)
 Table 64. Global Cyclosporine API Price (US$/Ton) by Application (2026-2031)
 Table 65. CURIA ITALY SRL Cyclosporine API Company Information
 Table 66. CURIA ITALY SRL Cyclosporine API Specification and Application
 Table 67. CURIA ITALY SRL Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. CURIA ITALY SRL Main Business and Markets Served
 Table 69. CURIA ITALY SRL Recent Developments/Updates
 Table 70. TEVA PHARMACEUTICAL INDUSTRIES LTD Cyclosporine API Company Information
 Table 71. TEVA PHARMACEUTICAL INDUSTRIES LTD Cyclosporine API Specification and Application
 Table 72. TEVA PHARMACEUTICAL INDUSTRIES LTD Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. TEVA PHARMACEUTICAL INDUSTRIES LTD Main Business and Markets Served
 Table 74. TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
 Table 75. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Cyclosporine API Company Information
 Table 76. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Cyclosporine API Specification and Application
 Table 77. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Main Business and Markets Served
 Table 79. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Recent Developments/Updates
 Table 80. CONCORD BIOTECH LTD Cyclosporine API Company Information
 Table 81. CONCORD BIOTECH LTD Cyclosporine API Specification and Application
 Table 82. CONCORD BIOTECH LTD Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. CONCORD BIOTECH LTD Main Business and Markets Served
 Table 84. CONCORD BIOTECH LTD Recent Developments/Updates
 Table 85. APOTEX PHARMACHEM INC Cyclosporine API Company Information
 Table 86. APOTEX PHARMACHEM INC Cyclosporine API Specification and Application
 Table 87. APOTEX PHARMACHEM INC Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. APOTEX PHARMACHEM INC Main Business and Markets Served
 Table 89. APOTEX PHARMACHEM INC Recent Developments/Updates
 Table 90. CHEMWERTH INC Cyclosporine API Company Information
 Table 91. CHEMWERTH INC Cyclosporine API Specification and Application
 Table 92. CHEMWERTH INC Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. CHEMWERTH INC Main Business and Markets Served
 Table 94. CHEMWERTH INC Recent Developments/Updates
 Table 95. ABBVIE INC Cyclosporine API Company Information
 Table 96. ABBVIE INC Cyclosporine API Specification and Application
 Table 97. ABBVIE INC Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. ABBVIE INC Main Business and Markets Served
 Table 99. ABBVIE INC Recent Developments/Updates
 Table 100. CKD BIO CORP Cyclosporine API Company Information
 Table 101. CKD BIO CORP Cyclosporine API Specification and Application
 Table 102. CKD BIO CORP Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. CKD BIO CORP Main Business and Markets Served
 Table 104. CKD BIO CORP Recent Developments/Updates
 Table 105. ZHEJIANG RUIBANG LABORATORIES Cyclosporine API Company Information
 Table 106. ZHEJIANG RUIBANG LABORATORIES Cyclosporine API Specification and Application
 Table 107. ZHEJIANG RUIBANG LABORATORIES Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. ZHEJIANG RUIBANG LABORATORIES Main Business and Markets Served
 Table 109. ZHEJIANG RUIBANG LABORATORIES Recent Developments/Updates
 Table 110. HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Cyclosporine API Company Information
 Table 111. HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Cyclosporine API Specification and Application
 Table 112. HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Main Business and Markets Served
 Table 114. HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD Recent Developments/Updates
 Table 115. Guangdong Tesunde Pharmaceutical Cyclosporine API Company Information
 Table 116. Guangdong Tesunde Pharmaceutical Cyclosporine API Specification and Application
 Table 117. Guangdong Tesunde Pharmaceutical Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Guangdong Tesunde Pharmaceutical Main Business and Markets Served
 Table 119. Guangdong Tesunde Pharmaceutical Recent Developments/Updates
 Table 120. Fujian Kerui Pharmaceutical Cyclosporine API Company Information
 Table 121. Fujian Kerui Pharmaceutical Cyclosporine API Specification and Application
 Table 122. Fujian Kerui Pharmaceutical Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Fujian Kerui Pharmaceutical Main Business and Markets Served
 Table 124. Fujian Kerui Pharmaceutical Recent Developments/Updates
 Table 125. North China Pharmaceutical Huasheng Cyclosporine API Company Information
 Table 126. North China Pharmaceutical Huasheng Cyclosporine API Specification and Application
 Table 127. North China Pharmaceutical Huasheng Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. North China Pharmaceutical Huasheng Main Business and Markets Served
 Table 129. North China Pharmaceutical Huasheng Recent Developments/Updates
 Table 130. Sinopharm Sichuan Kang Pharmaceutical Cyclosporine API Company Information
 Table 131. Sinopharm Sichuan Kang Pharmaceutical Cyclosporine API Specification and Application
 Table 132. Sinopharm Sichuan Kang Pharmaceutical Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. Sinopharm Sichuan Kang Pharmaceutical Main Business and Markets Served
 Table 134. Sinopharm Sichuan Kang Pharmaceutical Recent Developments/Updates
 Table 135. Jiangsu Joyoung Biopharmaceuticals Cyclosporine API Company Information
 Table 136. Jiangsu Joyoung Biopharmaceuticals Cyclosporine API Specification and Application
 Table 137. Jiangsu Joyoung Biopharmaceuticals Cyclosporine API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 138. Jiangsu Joyoung Biopharmaceuticals Main Business and Markets Served
 Table 139. Jiangsu Joyoung Biopharmaceuticals Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Cyclosporine API Distributors List
 Table 143. Cyclosporine API Customers List
 Table 144. Cyclosporine API Market Trends
 Table 145. Cyclosporine API Market Drivers
 Table 146. Cyclosporine API Market Challenges
 Table 147. Cyclosporine API Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cyclosporine API
 Figure 2. Global Cyclosporine API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Cyclosporine API Market Share by Type: 2024 VS 2031
 Figure 4. Purity≥99% Product Picture
 Figure 5. Purity<99% Product Picture
 Figure 6. Global Cyclosporine API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Cyclosporine API Market Share by Application: 2024 VS 2031
 Figure 8. Capsule
 Figure 9. Tablet
 Figure 10. Injection
 Figure 11. Eye Drops
 Figure 12. Eye Gel
 Figure 13. Eye Cream
 Figure 14. Oral Solution
 Figure 15. Granules
 Figure 16. Global Cyclosporine API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Cyclosporine API Production Value (US$ Million) & (2020-2031)
 Figure 18. Global Cyclosporine API Production Capacity (Tons) & (2020-2031)
 Figure 19. Global Cyclosporine API Production (Tons) & (2020-2031)
 Figure 20. Global Cyclosporine API Average Price (US$/Ton) & (2020-2031)
 Figure 21. Cyclosporine API Report Years Considered
 Figure 22. Cyclosporine API Production Share by Manufacturers in 2024
 Figure 23. Global Cyclosporine API Production Value Share by Manufacturers (2024)
 Figure 24. Cyclosporine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. The Global 5 and 10 Largest Players: Market Share by Cyclosporine API Revenue in 2024
 Figure 26. Global Cyclosporine API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 27. Global Cyclosporine API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 28. Global Cyclosporine API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 29. Global Cyclosporine API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 30. North America Cyclosporine API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 31. Europe Cyclosporine API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 32. China Cyclosporine API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 33. Japan Cyclosporine API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 34. Global Cyclosporine API Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 35. Global Cyclosporine API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 36. North America Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 37. North America Cyclosporine API Consumption Market Share by Country (2020-2031)
 Figure 38. U.S. Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. Canada Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. Europe Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Europe Cyclosporine API Consumption Market Share by Country (2020-2031)
 Figure 42. Germany Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 43. France Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. U.K. Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. Italy Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. Russia Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. Asia Pacific Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. Asia Pacific Cyclosporine API Consumption Market Share by Region (2020-2031)
 Figure 49. China Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. Japan Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 51. South Korea Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. China Taiwan Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. Southeast Asia Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. India Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Latin America, Middle East & Africa Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 56. Latin America, Middle East & Africa Cyclosporine API Consumption Market Share by Country (2020-2031)
 Figure 57. Mexico Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 58. Brazil Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 59. Turkey Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 60. GCC Countries Cyclosporine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 61. Global Production Market Share of Cyclosporine API by Type (2020-2031)
 Figure 62. Global Production Value Market Share of Cyclosporine API by Type (2020-2031)
 Figure 63. Global Cyclosporine API Price (US$/Ton) by Type (2020-2031)
 Figure 64. Global Production Market Share of Cyclosporine API by Application (2020-2031)
 Figure 65. Global Production Value Market Share of Cyclosporine API by Application (2020-2031)
 Figure 66. Global Cyclosporine API Price (US$/Ton) by Application (2020-2031)
 Figure 67. Cyclosporine API Value Chain
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Immunosuppressants API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Api Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chemical API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Doxycycline API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
API Derivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Everolimus API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Epalrestat API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti infective API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Carbapenem API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cytarabine API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Psychiatric API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 Drug API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Aminocaproic Acid API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acetaminophen API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kanamycin Sulfate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Kidney Disease Drugs Market Research Report 2025
Amphotericin B API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Miglustat API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ulipristal Acetate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharma Grade Cyclodextrin Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions